Allena Pharmaceuticals Valuation
| ALNAQDelisted Stock | USD 0 0.00 0.00% |
Allena Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Allena Pharmaceuticals from analyzing the firm fundamentals such as Current Valuation of (181.84 K), return on equity of -5.41, and Shares Owned By Insiders of 0.92 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Allena Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Allena Pharmaceuticals is based on 3 months time horizon. Increasing Allena Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Allena Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 0, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.002 | Real 0.0019 | Hype 0.0025 | Naive 0.007163 |
The intrinsic value of Allena Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Allena Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Allena Pharmaceuticals helps investors to forecast how Allena pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Allena Pharmaceuticals more accurately as focusing exclusively on Allena Pharmaceuticals' fundamentals will not take into account other important factors: Allena Pharmaceuticals Total Value Analysis
Allena Pharmaceuticals is presently forecasted to have takeover price of (181.84 K) with market capitalization of 244.17 K, debt of 5.28 M, and cash on hands of 6.59 M. The negative valuation of Allena Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Allena Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(181.84 K) | 244.17 K | 5.28 M | 6.59 M |
Allena Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Allena is to check how much profit was generated for every dollar of assets it reports. Allena Pharmaceuticals shows a negative utilization of assets of -1.07 percent, losing $0.0107 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Allena Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Allena Pharmaceuticals Ownership Allocation
Allena Pharmaceuticals holds a total of 122.08 Million outstanding shares. Almost 98.82 percent of Allena Pharmaceuticals outstanding shares are held by general public with 0.92 (percent) owned by insiders and only 0.26 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Allena Pharmaceuticals Profitability Analysis
Net Loss for the year was (48.66 M) with profit before overhead, payroll, taxes, and interest of 0.About Allena Pharmaceuticals Valuation
The pink sheet valuation mechanism determines Allena Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Allena Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Allena Pharmaceuticals. We calculate exposure to Allena Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Allena Pharmaceuticals's related companies.Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. On September 2, 2022, Allena Pharmaceuticals, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Allena Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 12 people.
8 Steps to conduct Allena Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Allena Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Allena Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Allena Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Allena Pharmaceuticals' revenue streams: Identify Allena Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Allena Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Allena Pharmaceuticals' growth potential: Evaluate Allena Pharmaceuticals' management, business model, and growth potential.
- Determine Allena Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Allena Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Allena Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Allena Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 83 M | |
| Retained Earnings | -246.5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Allena Pink Sheet
If you are still planning to invest in Allena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allena Pharmaceuticals' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |